Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-18

Clinical Trial Update: Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates the effect of melatonin on sleep disturbances in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Kuhnil Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN